Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled salmeterol before bronchial allergen or allergen plus LPS challenge in mild asthma
NL-OMON26298Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of salmeterol in asthma and allergic asthma (4 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Total leukocyte counts and differentials, Neutrophil activation and 7 more. Started Jun 2009; status: active, not recruiting.
02
Drugs
salmeterol
03
Conditions
asthmaallergic asthma
Beyond the preview
Go deeper on NL-OMON26298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26298.